Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole in Neoadjuvant Treatment of Locally Advanced Rectal Cancer
NCT06793137Phase 2Recruiting
- Sponsor
- A.C.Camargo Cancer Center
- Start
- Jul 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole in rectal cancer, sponsored by A.C.Camargo Cancer Center. Started Jul 2024; status: recruiting.
02
Drugs
metronidazole
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06793137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793137.